Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Announcement under Regulation 30 (LODR)-Change in Directorate

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE ·

Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we inform you that w.e.f. 18-October-2025, Dr. Umesh Luthra has resigned as Independent Director and Dr. Vijay Ojha has been appointed as an additional director and Independent Director of the Company. Annexures containing details as prescribed vide SEBI circular dated July 13, 2013 are enclosed. A copy of the letter received from Dr. Umesh Luthra for his resignation is enclosed.

View Attachment

6ix hasn’t read this filing yet.

View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases